It has become well accepted that altered glycosylation is a hallmark of cancer progression, including mCRPC, and complex-type glycans lacking polylactosamine have been observed on PSMA derived from prostate cancer tissue and serum, while primarily high-mannose forms have been reported in the LNCaP setting [51]. The gene discussed is FOLH1; the disease is prostate cancer.